1. Igarashi, Miki, Hayakawa, Tetsuhiko, Tanabe, Haruka, Nishida, Akari, Kimura, Ikuo. 2022. Intestinal GPR119 activation by microbiota-derived metabolites impacts feeding behavior and energy metabolism. In Molecular metabolism, 67, 101649. doi:10.1016/j.molmet.2022.101649. https://pubmed.ncbi.nlm.nih.gov/36462626/
2. Chepurny, Oleg G, Bertinetti, Daniela, Diskar, Mandy, Herberg, Friedrich W, Holz, George G. 2013. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag. In Molecular endocrinology (Baltimore, Md.), 27, 1267-82. doi:10.1210/me.2013-1029. https://pubmed.ncbi.nlm.nih.gov/23798572/
3. Yang, Jin Won, Kim, Hyo Seon, Im, Ji Hye, Kim, Sang Kyum, Kang, Keon Wook. 2015. GPR119: a promising target for nonalcoholic fatty liver disease. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 30, 324-35. doi:10.1096/fj.15-273771. https://pubmed.ncbi.nlm.nih.gov/26399788/
4. Markovics, Arnold, Angyal, Ágnes, Tóth, Kinga Fanni, Bíró, Tamás, Oláh, Attila. 2020. GPR119 Is a Potent Regulator of Human Sebocyte Biology. In The Journal of investigative dermatology, 140, 1909-1918.e8. doi:10.1016/j.jid.2020.02.011. https://pubmed.ncbi.nlm.nih.gov/32142797/
5. Chepurny, Oleg G, Holz, George G, Roe, Michael W, Leech, Colin A. 2016. GPR119 Agonist AS1269574 Activates TRPA1 Cation Channels to Stimulate GLP-1 Secretion. In Molecular endocrinology (Baltimore, Md.), 30, 614-29. doi:10.1210/me.2015-1306. https://pubmed.ncbi.nlm.nih.gov/27082897/
6. Lee, Seung-Ho, Park, Hansu, Yang, Eun-Kyoung, Chae, Yuna, Kim, Mi-Kyung. 2023. GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NFκB signaling. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 166, 115345. doi:10.1016/j.biopha.2023.115345. https://pubmed.ncbi.nlm.nih.gov/37657264/
智鼠故事 
